Press Releases

GlobeNewswire, Inc.

Germantown, Maryland, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Breaking the Business Class Price Barrier For years, business class travel has remained financially out of reach for most travelers, despite the significant comfort advantages on long-haul...

EIN Presswire

How to transform workforce development into strategic infrastructure through skill validation LONDON, UNITED KINGDOM, August 7, 2026 /⁨EINPresswire.com⁩/ -- In an article published on Business Reporter, Alexis Ahmed, Cybersecurity Consultant and...

GlobeNewswire, Inc.

Confirmatory Phase 3 trial of roluperidone (MIN-101C19) ongoing with topline efficacy data expected 2H 2027 Scientific Advisory Board of leading experts in psychiatry and neuroscience established to guide the confirmatory Phase 3 trial of...

EIN Presswire

The world's first all-in-one platform for both Dubai company formation and US LLC setup, one login to launch, track, and run everything from a single dashboard.

EIN Presswire

eSUN 24th Anniversary Sale Launches on Amazon France WUHAN, CHINA, August 7, 2026 /⁨EINPresswire.com⁩/ -- For 3D printing hobbyists, designers, and engineers, choosing the right 3D printing filament often determines the success of a project far...

GlobeNewswire, Inc.

Seoul, Korea, Aug. 07, 2026 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the second...

EIN Presswire

KYIV, UKRAINE, August 7, 2026 /⁨EINPresswire.com⁩/ -- Kazakhstan is increasing oil production, while at the same time becoming even more dependent on transport infrastructure that it controls only partially.

GlobeNewswire, Inc.

MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus Approval further strengthens MVA-BN’s position in supporting global public health preparedness...

EIN Presswire

Former TikTok and Meta executive Mattia Frese joins Foap as Business Director to drive growth across Western Europe, the Nordics and social commerce.

ECB - European Central Bank

Summary At its meeting on 23 July 2026, the Governing Council decided to keep the three key ECB interest rates unchanged.

GlobeNewswire, Inc.

MYQORZO® (aficamten) Net Product Revenue of $25 Million Full Results from ACACIA-HCM to be Presented in Hot Line Session at ESC; Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in Q4 2026 MYQORZO Launched in Germany,...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the...

EIN Presswire

Europe Electric Garbage Van Market Expands with Rising Fleet Electrification and Sustainable Waste Management Initiatives.

GlobeNewswire, Inc.

Varsetatug masetecan (“Varseta-M”) Program: - Phase 1 monotherapy update in advanced colorectal cancer (CRC) expected by the end of 2026. Registrational study planned for initiation in 1H 2027 - - Phase 1 study in combination with bevacizumab in...

GlobeNewswire, Inc.

PiNACLE pivotal clinical trial evaluating ronde-cel in 3L+ patients with LBCL on track to report additional data in second half of 2026, with pivotal data expected mid-2027 and BLA submission expected to follow in the second half of 2027 Presented...

GlobeNewswire, Inc.

Following U.S. regulatory discussions, accelerated approval strategy remains intact, supported by DENALI Part 2 Enrollment completed in Part 2a and 2b of the DENALI trial; Part 2c is enrolling DENALI Part 2 topline readout expected in 1H 2027 to...

GlobeNewswire, Inc.

- Duchenne (SGT-003): SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as of August 4, 2026 - - Solid expects to meet with the FDA in late Q4 2026 to discuss the SGT-003 data...

GlobeNewswire, Inc.

NDA submission for azetukalner on track for Q3 2026 following pre-NDA meeting with FDA Phase 3 X-TOLE3 study in FOS and X-ACKT study in PGTCS continue to enroll Three Phase 3 studies of azetukalner in neuropsychiatry continue to advance, with...

GlobeNewswire, Inc.

Strong first full quarter of AVLAYAH™ (tividenofusp alfa-eknm) launch generated $3.6 million in net product revenue Advanced TransportVehicle™ portfolio with two Alzheimer’s disease programs now in clinical development $195 million in gross...

GlobeNewswire, Inc.

LONDON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pixalate, an ad fraud and privacy compliance platform, today released the Q2 2026 Web Seller Trust Index (STI) 2.0 rankings.